Strides Arcolab Ltd said on Monday that it had agreed to form an equal joint venture with Turkey's Abdi Ibrahim to sell Strides' specialty drug products in Turkey.
The Turkish pharmaceutical market is currently valued at $6.6 billion, Strides said in a statement.
{{^htLoading}} {{/htLoading}}
Check India news real-time updates, latest news on Hindustan Times and more across India.
Advertisement
{{/htLoading}}{{#usCountry}}